Results 61 to 70 of about 211,965 (305)

The Medicare Part D Coverage Gap: Costs and Consequences in 2007 [PDF]

open access: yes, 2008
Analyzes data on Medicare Part D enrollees who reached the coverage gap and had to pay the full cost until they qualified for catastrophic coverage, who then stopped taking their medications or bought cheaper ones, and who received catastrophic ...
Elizabeth Hargrave   +3 more
core  

Epidemiology of Cancer‐Associated Venous Thromboembolism Across the United States

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Prior epidemiological studies on cancer‐associated venous thromboembolism (VTE) were limited by homogenous patient populations. We leverage Cosmos, a collaborative dataset of Epic electronic health record systems, to conduct an updated evaluation of cancer‐associated VTE in the United States (US).
Barbara D. Lam   +7 more
wiley   +1 more source

One Fish, Two Fish, Red Fish, Blue Fish: Effects of Price Frames, Brand Names, and Choice Set Size in Medicare Part D Insurance Plan Decisions [PDF]

open access: yes, 2012
Because many seniors choose Medicare Part D plans offering poorer coverage at greater cost, the authors examined the effect of price frames, brand names, and choice set size on participants\u27 ability to choose the lowest cost plan.
Barnes, Andrew J.   +4 more
core   +2 more sources

The Cost of the National Disability Insurance Scheme: Australia's Print‐Media Discourse

open access: yesAustralian Journal of Social Issues, EarlyView.
ABSTRACT This paper examines the way that Australian newspapers have framed the cost of the National Disability Insurance Scheme (NDIS). Introduced in 2013, the NDIS represented a major change in Australia's disability support policy, moving for the first time to a nationwide universal insurance model.
Meera Chinnappa   +2 more
wiley   +1 more source

Federal Employees Health Benefits Program (FEHBP): Available Health Insurance Options [PDF]

open access: yes, 2012
FEHBP is generally available to employees, annuitants, and their dependents. Eligible individuals may elect coverage in an approved health benefits plan for either individual or family coverage.
Mach, Annie L
core   +3 more sources

Cost Utility Analysis of Fluticasone Exhalation Delivery System Versus Budesonide Nasal Irrigation for Chronic Rhinosinusitis With Nasal Polyps

open access: yesInternational Forum of Allergy &Rhinology, EarlyView.
ABSTRACT Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is managed after sinus surgery with topical corticosteroids. Given limited distribution of nasal steroid sprays, patients have the option of either steroid nasal irrigation (SNI) or exhalation delivery system with fluticasone (EDS‐FLU).
Daniel Xiao   +3 more
wiley   +1 more source

Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia. [PDF]

open access: yesPLoS ONE, 2017
Gifts from pharmaceutical companies are believed to influence prescribing behavior, but few studies have addressed the association between industry gifts to physicians and drug costs, prescription volume, or preference for generic drugs.
Susan F Wood   +6 more
doaj   +1 more source

Choosing a Medicare Part D Plan: Are Medicare Beneficiaries Choosing Low-Cost Plans? [PDF]

open access: yes, 2009
Examines whether Medicare enrollees choose the prescription drug plans with the lowest premiums and out-of-pocket expenses for them from among multiple private insurance options.
Jonathan Gruber
core  

Gabepentinoids and Benzodiazepines in Medicare Part D [PDF]

open access: yesJournal of the American Society of Nephrology, 2018
I have read with interest the observational study regarding risks of adverse outcomes associated with gapapentin and pregabalin use.[1][1] The authors adeptly analyzed data in the US Renal Data System database, including Medicare Part D prescription drug events ( i.e.
openaire   +2 more sources

Does Medicare Part D Protect the Elderly from Financial Risk? [PDF]

open access: yes
The Medicare Modernization Act of 2003 added the Part D prescription drug benefit to the Medicare program. This addition, which became effective in 2006, increased Medicare program costs by more than 10 percent in order to provide, for the first time ...
Gary V. Engelhardt, Jonathan Gruber
core   +1 more source

Home - About - Disclaimer - Privacy